Skip to content
Review

Structures of Hepatitis B Virus Subviral Particles and Identification of Potential Druggable Pockets for the Discovery of Antiviral Agents.

Jul 2026 · Antiviral Research · pp. 106484 · 0 citations · 67 references
Medicine

TL;DR

The identification of two possible non-symmetrical small-molecule binding pockets at the dimer interface, and one in the CYL zing finger region are reported, and the druggability of these pockets, as well as unresolved issues in SVP biology, are discussed.

Abstract

The small envelope protein of hepatitis B virus (S-HBs) is the principal component of the spherical and filamentous noninfectious subviral particles (SVPs) produced by infected hepatocytes, likely functioning as immune tolerizing agents critical to the establishment and maintenance of chronic infection. The structural features of S-HBs in the context of SVPs have been recently elucidated by several groups using high resolution cryo-EM techniques. In this review, we resolve the commonalities and differences between these reports. The basic unit of SVPs is an S-HBs dimer which is stabilized by hydrophobic interactions between adjacent protomer helices (TH2/TH2 and TH1/EH4, nomenclature by Wang et al., 2024), forming a helical transmembrane core. The adjacent protomer cytosolic and antigenic loops (CYL and AGL, respectively) contribute to dimer stability through salt bridges and intermolecular disulfide bonds; the CYL likely features a zinc finger motif coordinated by C48, H60, C65 and C69, which were shown to be essential. Oligomerization of dimers into trimeric and multiple tetrameric arrangements of dimers during SVP morphogenesis is aided by conformational plasticity within the helical core. Taking previous cell biological studies into account, it is envisioned that in the ER membrane topology and dimerization of S-HBs occur co-translationally, initiating an SVP budding process that completes in the downstream ERGIC and/or Golgi compartments. We report on the identification of two possible non-symmetrical small-molecule binding pockets at the dimer interface, and one in the CYL zing finger region. The druggability of these pockets, as well as unresolved issues in SVP biology, are discussed.

View source

Similar papers

Review

Structural Overview of Herpesvirus Tegument Proteins

Current knowledge on the structural features of herpesvirus tegument proteins are summarized, highlighting the structure-based functional implications, including their potential as targets for antiviral drug development.

Huiping He, Shuang Liao, Dong-Dong Gu et al. · 0 citations
Open access Jul 2026

Structure-based design of stable recombinant hepatitis C virus E1E2 heterodimers

Hepatitis C virus (HCV) affects 47 million people and causes 239,000 deaths annually, yet no vaccine is on the horizon. Generating a stable native-like mimic of the envelope complex E1E2, the only target for known neutralizing antibodies, is an important aim for HCV vaccine development. Starting from a recombinant E1E2...

Joan Capella-Pujol, Fabian Mulder, F. Cannac et al. · 1 citation
Review Aug 2026

Inhibitors of the Influenza Virus Polymerase Basic 2 (PB2): Recent Advances and Future Perspectives.

Influenza, an acute respiratory infectious disease caused by influenza viruses, poses a serious public health threat with high infectivity and virulence. Existing antivirals suffer from numerous limitations, such as the frequent emergence of drug resistance and inconvenient administration, highlighting the urgent need...

Xinru Zhang, Heng Jia, Xianglong Wang et al. · 0 citations
Jul 2026

Identification of potential inhibitors of dengue virus ns5 methyltransferase and polymerase domains through virtual screening and molecular dynamics studies

Molecular dynamics simulations showed that the S-adenosylmethionine (SAM)-binding site ligand formed a more stable complex with lower root-mean-square deviation (RMSD) and reduced flexibility, indicating a promising lead candidate for further optimization and experimental validation against dengue virus NS5.

Nabeel Haider, Abolfazl Zare, Yi Zhou et al. · 1 citation
Open access Aug 2026

The conserved bridging domain on HCV E1E2 glycoprotein complex is targeted by neutralizing antibodies from diverse lineages.

Describing the genetic, structural, functional, and epitope features of 25 BD-directed nAbs isolated from HCV-infected individuals or immunized macaques underscores BD as a promising target for rational HCV vaccine design.

Fang Chen, Yen Thi Kim Nguyen, Yi-Zong Lee et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.